Eloxx Pharmaceuticals, Inc. (ELOX)
15.46
-1.31
(-7.81%)
USD |
OTCM |
Sep 01, 16:00
15.46
0.00 (0.00%)
After-Hours: 19:29
Eloxx Pharmaceuticals Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -17.99M |
| June 30, 2023 | -21.49M |
| March 31, 2023 | -29.17M |
| December 31, 2022 | -31.84M |
| September 30, 2022 | -36.12M |
| June 30, 2022 | -36.76M |
| March 31, 2022 | -36.81M |
| December 31, 2021 | -35.00M |
| September 30, 2021 | -29.74M |
| June 30, 2021 | -27.41M |
| March 31, 2021 | -23.93M |
| December 31, 2020 | -28.17M |
| September 30, 2020 | -32.76M |
| June 30, 2020 | -38.82M |
| March 31, 2020 | -42.13M |
| December 31, 2019 | -39.39M |
| September 30, 2019 | -39.19M |
| June 30, 2019 | -35.97M |
| March 31, 2019 | -34.86M |
| December 31, 2018 | -31.37M |
| September 30, 2018 | -22.82M |
| June 30, 2018 | -15.12M |
| March 31, 2018 | -7.048M |
| June 30, 2017 | -1.925M |
| March 31, 2017 | -2.131M |
| Date | Value |
|---|---|
| December 31, 2016 | -2.567M |
| September 30, 2016 | -3.118M |
| June 30, 2016 | -3.676M |
| March 31, 2016 | -5.428M |
| December 31, 2015 | -5.993M |
| September 30, 2015 | -6.538M |
| June 30, 2015 | -7.345M |
| March 31, 2015 | -6.097M |
| December 31, 2014 | -6.248M |
| September 30, 2014 | -6.137M |
| June 30, 2014 | -4.868M |
| March 31, 2014 | -4.596M |
| December 31, 2013 | -4.793M |
| September 30, 2013 | -3.937M |
| June 30, 2013 | -3.903M |
| March 31, 2013 | -4.064M |
| December 31, 2012 | -3.29M |
| September 30, 2012 | -3.932M |
| June 30, 2012 | -4.386M |
| March 31, 2012 | -4.302M |
| December 31, 2011 | -4.612M |
| September 30, 2011 | -4.876M |
| June 30, 2011 | -5.391M |
| March 31, 2011 | -7.009M |
| December 31, 2010 | -6.246M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Filana Therapeutics, Inc. | -28.70M |
| CorMedix, Inc. | 253.62M |
| Cannabis Global, Inc. | -0.2899M |
| Breakthrough Chemistry, Inc. | -0.0066M |
| BioStem Technologies, Inc. | -5.919M |